3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Lung Neoplasms
9
NSCLC
3
Brain Neoplasms
3
Neoplasms
2
Squamous Cell Carcinoma of Lung
1
Non-squamous Non-small Cell Lung Cancer
1
Non-small Cell Lung Cancer Metastatic
1
Non-Small-Cell Lung
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Esophageal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Bronchial Neoplasms
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Carboplatin
4
Pemetrexed
3
Bevacizumab
3
osimertinib
2
Radiosurgery
2
Gemcitabine
2
Docetaxel
2
Cisplatin
2
trametinib
1
nazartinib
1
icotinib
1
durvalumab
1
cemiplimab
1
atezolizumab
1
Watchful Waiting
1
Vinorelbine
1
Technetium Tc 99m Aggregated Albumin
1
Radiotherapy
1
Platinum Compounds
1
Paclitaxel
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bronchial Neoplasms
×
icotinib
×
Clear all
NCT02264210
2024-09-25
CORIN
Sun Yat-sen University
Phase 2
Completed
128 enrolled
9 charts